Zosano Pharma Corporation – Trademark Portfolio

Entity Type: 03

Zosano Pharma Corporation holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ZOSANO PHARMA. The owner is based in Fremont, CA.

34790 Ardentech Court

Fremont, CA 94555

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zosano Pharma Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zosano Pharma Corporation have?

Zosano Pharma Corporation has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned.

What trademark classes does Zosano Pharma Corporation file in?

Zosano Pharma Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Zosano Pharma Corporation's most well-known trademarks?

Zosano Pharma Corporation's registered trademark portfolio includes well-known marks such as ZOSANO PHARMA. These are among 1 currently registered trademark in the portfolio.

What is Zosano Pharma Corporation's trademark registration success rate?

Zosano Pharma Corporation has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.